Table 2.
Intraoperative vital signs of patients in both groups.
| Group butorphanol (n = 30) | Group control (n = 30) | |||||
|---|---|---|---|---|---|---|
| HR (bpm) | SPO2 (%) | MAP (mmHg) | HR (bpm) | SPO2 (%) | MAP (mmHg) | |
| T0 | 78.3 (13.5) | 97.7 (2.4) | 113.1 (15.1) | 68 (9.8) | 99.8 (0.6) | 105.5 (10.5) |
| T1 | 76.4 (13.7) | 97.6 (2.8) | 116.1 (17.2) | 66 (11.7) | 99.8 (0.5) | 100.2 (12.1) |
| T2 | 75.3 (12.4) | 97.8 (2.1) | 112.1 (12.1) | 65.6 (7.9) | 99.8 (0.5) | 98.9 (13.2) |
| T3 | 76.1 (12.9) | 97.3 (2.5) | 112.2 (13.6) | 65.2 (7.5) | 99 (1.3) | 98.9 (12.4) |
| T4 | 76 (11.2) | 97.1 (2.1) | 110.9 (12.2) | 64.9 (7.5) | 98.0 (1.9) | 97.8 (11.7) |
| T5 | 75.6 (11.4) | 97.4 (2.0) | 109.9 (12.7) | 66.8 (7.7) | 98.7 (1.5) | 98.6 (10.1) |